Automated for the people

Last month, the Global Biological Standards Institute (GBSI) held its annual meeting, this time with a focus on automation tools whose low cost could enable wider access by researchers for enhancing the reproducibility of preclinical research.

“Affordable, accessible tools -- robots, instruments, software, etc. -- are contributing to democratize scientific discovery, putting sophisticated but affordable technology in the hands of more scientists than ever before, and making protocols and results easier to share,” GBSI founding President Leonard Freedman told BioCentury after the meeting. ...